Department of Internal Medicine, Taipei Veterans General Hospital, Taoyuan Branch, Taoyuan, Taiwan; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Headache. 2014 Apr;54(4):610-8. doi: 10.1111/head.12328. Epub 2014 Mar 25.
Headache disorder is a major public health issue and is a great burden for the person, the health care system, and society. This article reviews epidemiological surveys of primary headache disorders including migraine and tension-type headache (TTH) among adults in the Asia-Pacific region using the International Classification of Headache Disorders (ICHD), first or second edition. Chronic daily headache (CDH), which is not an official diagnosis in the ICHD, was also reviewed. In the Asia-Pacific region, the median (range) 1-year prevalence of primary headache disorders was 9.1% (1.5-22.8%) for migraine, 16.2% (10.8-33.8%) for TTH, and 2.9% (1.0-3.9%) for CDH. The 1-year prevalence of migraine and TTH were rather consistent; however, the extremes in the 1-year prevalence of migraine in earlier studies from Hong Kong (1.5%) and South Korea (22.3%) were not repeated in later surveys (Hong Kong: 12.5%; South Korea: 6%). According to the United Nations, the estimated population of the Asia-Pacific region was 3.85 billion in 2010, equaling to headache suffers of 350 million patients with migraine, 624 million with TTH, and 112 million with CDH; many remain to be treated. The prevalence of headache disorders has remained stable over the last 2 decades in this region, where the diversity of geography, race, and development is wide. Thus, the pursuit of better headache care in this region might be our next challenge.
头痛障碍是一个主要的公共卫生问题，给个人、医疗保健系统和社会都带来了巨大的负担。本文综述了亚太地区使用国际头痛疾病分类（ICHD）第一或第二版的成人原发性头痛障碍（包括偏头痛和紧张型头痛[TTH]）的流行病学调查。还综述了非 ICHD 正式诊断的慢性每日头痛（CDH）。在亚太地区，原发性头痛障碍的 1 年患病率中位数（范围）为偏头痛 9.1%（1.5-22.8%），TTH 16.2%（10.8-33.8%）和 CDH 2.9%（1.0-3.9%）。偏头痛和 TTH 的 1 年患病率相当一致；然而，香港（1.5%）和韩国（22.3%）早期研究中偏头痛的 1 年患病率极值在后来的调查中并未重现（香港：12.5%；韩国：6%）。根据联合国的数据，2010 年亚太地区的估计人口为 38.5 亿，相当于 3.5 亿偏头痛患者、6.24 亿 TTH 患者和 1.12 亿 CDH 患者；还有许多人需要治疗。在过去的 20 年里，该地区头痛障碍的患病率保持稳定，该地区的地理、种族和发展差异很大。因此，在该地区追求更好的头痛治疗可能是我们的下一个挑战。
